RA Capital Management is a multi-stage investment manager specializing in evidence-based investing in healthcare and life science companies. The firm supports company formation and development of drugs, medical devices, diagnostics, and research tools, with a global portfolio across therapeutic areas. RA Capital's TechAtlas division provides market intelligence and scientific analysis, contributing to the firm's strategic investment decisions.
Recent Transactions involving RA Capital Management
Deal | Target | Platform | Buyer | Industry |
---|---|---|---|---|
Aeglea BioTherapeutics Announces Acquisition of Spyre Therapeutics |
Spyre Therapeutics |
Aeglea BioTherapeutics |
EcoR1 CapitalFairmount Funds ManagementVenrock Healthcare Capital PartnersCommodore CapitalPerceptive AdvisorsRTW InvestmentsCormorant Asset ManagementDriehaus Capital ManagementSurveyor CapitalWellington Management CompanyUndisclosed Institutional InvestorsFidelity Management and ResearchRA Capital ManagementDeepTrack Capital |
Biotechnology Research |
|
|
|
The Lower and Middle Market M&A Platform
See how PrivSource can help you close more deals.
Learn more →